ambrisentan is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Aurobindo Pharma Limited. The primary component is Ambrisentan.
Product ID | 59651-495_82e51c75-fb78-4ad3-8bce-5e0581d60014 |
NDC | 59651-495 |
Product Type | Human Prescription Drug |
Proprietary Name | ambrisentan |
Generic Name | Ambrisentan |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2022-07-21 |
Marketing Category | ANDA / |
Application Number | ANDA216531 |
Labeler Name | Aurobindo Pharma Limited |
Substance Name | AMBRISENTAN |
Active Ingredient Strength | 10 mg/1 |
Pharm Classes | Endothelin Receptor Antagonist [EPC], Endothelin Receptor Antagonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2022-07-21 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
0378-4270 | Ambrisentan | ambrisentan |
0378-4271 | Ambrisentan | ambrisentan |
0591-2405 | Ambrisentan | Ambrisentan |
0591-2406 | Ambrisentan | Ambrisentan |
42291-018 | AMBRISENTAN | AMBRISENTAN |
42291-019 | AMBRISENTAN | AMBRISENTAN |
42794-051 | AMBRISENTAN | AMBRISENTAN |
42794-052 | AMBRISENTAN | AMBRISENTAN |
47335-236 | ambrisentan | ambrisentan |
47335-237 | ambrisentan | ambrisentan |
49884-353 | Ambrisentan | Ambrisentan |
49884-354 | Ambrisentan | Ambrisentan |
59651-494 | ambrisentan | ambrisentan |
59651-495 | ambrisentan | ambrisentan |
60505-4552 | Ambrisentan | AMBRISENTAN |
60505-4553 | Ambrisentan | AMBRISENTAN |
69097-386 | Ambrisentan | Ambrisentan |
69097-387 | Ambrisentan | Ambrisentan |
70710-1179 | Ambrisentan | Ambrisentan |
70710-1180 | Ambrisentan | Ambrisentan |
70771-1363 | Ambrisentan | Ambrisentan |
70771-1364 | Ambrisentan | Ambrisentan |
76282-684 | Ambrisentan | Ambrisentan |
76282-685 | Ambrisentan | Ambrisentan |
61958-0801 | Letairis | AMBRISENTAN |
61958-0802 | Letairis | AMBRISENTAN |